Home  »  News   »  Sonoma Pharmaceuticals Inc. (SNOA): This Stock is ...

Sonoma Pharmaceuticals Inc. (SNOA): This Stock is set to Soar Above its Peers

At the end of the latest market close, Sonoma Pharmaceuticals Inc. (SNOA) was valued at $1.20. In that particular session, Stock kicked-off at the price of $1.21 while reaching the peak value of $1.2399 and lowest value recorded on the day was $1.1601. The stock current value is $2.09.Recently in News on January 25, 2023, Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products. Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including dermatology, eye, oral and nasal care, and wound care, today announced that Microcyn® Rx products have received a Distribution and Pricing Agreement (DAPA) for distribution by the Defense Logistics Agency (DLA). You can read further details here

Sonoma Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.6800 on 01/25/23, with the lowest value was $1.0800 for the same time period, recorded on 01/06/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Sonoma Pharmaceuticals Inc. (SNOA) full year performance was -68.50%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Sonoma Pharmaceuticals Inc. shares are logging -50.84% during the 52-week period from high price, and 108.93% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.00 and $4.25.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 81240672 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Sonoma Pharmaceuticals Inc. (SNOA) recorded performance in the market was 7.14%, having the revenues showcasing -41.46% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.61M, as it employees total of 12 workers.

The Analysts eye on Sonoma Pharmaceuticals Inc. (SNOA)

During the last month, 0 analysts gave the Sonoma Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.8731, with a change in the price was noted -0.69. In a similar fashion, Sonoma Pharmaceuticals Inc. posted a movement of -24.82% for the period of last 100 days, recording 1,261,013 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SNOA is recording 0.03 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Sonoma Pharmaceuticals Inc. (SNOA)

Raw Stochastic average of Sonoma Pharmaceuticals Inc. in the period of last 50 days is set at 64.88%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 64.88%. In the last 20 days, the company’s Stochastic %K was 58.38% and its Stochastic %D was recorded 56.65%.

Considering, the past performance of Sonoma Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 7.14%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -60.98%, alongside a downfall of -68.50% for the period of the last 12 months. The shares increased approximately by -11.11% in the 7-day charts and went down by 6.19% in the period of the last 30 days. Common stock shares were lifted by -41.46% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts